AMSTERDAM, The Netherlands, May 27, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced that its management will present a corporate overview at the Jefferies 2015 Global Healthcare Conference, to be held in New York City, June 1-4, 2015.
Date: June 1, 2015
Time: 10:00 a.m. (ET)
Speaking for uniQure: Matthew Kapusta, Chief Financial Officer
To access a simultaneous webcast of Mr. Kapusta's presentation via the internet, log on to the "Events" section on the Media page of the uniQure website at http://www.uniqure.com/news/calendar-of-events/.
A replay of the webcast will be available from uniQure's website for 90 days following the conference. Mr. Kapusta's presentation will be available for download in PDF format immediately following the conference presentation in the "Events" section of the Media page of uniQure's website at http://www.uniqure.com/news/calendar-of-events/.
About uniQure
uniQure is delivering on the promise of gene therapy through single treatments with potentially curative results. We have developed a modular platform to rapidly bring new disease-modifying therapies to patients with severe disorders. We are engaged in multiple partnerships and have obtained regulatory approval of our lead product, Glybera, in the European Union for a subset of patients with LPLD.